PNC Financial Services Group’s Outlook Therapeutics OTLK Stock Holding History

PNC Financial Services Group’s Portfolio OTLK Stock Details OTLK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$39.8K	Hold	25,000	–	–	﹤0.01%	3464
2026 Q1	$5.15K	Buy	25,000 +10,000	+67%	+$4.32K	﹤0.01%	4254
2025 Q4	$23.7K	Buy	15,000 +3,472	+30%	+$5.55K	﹤0.01%	3587
2025 Q3	$12.2K	Sell	11,528 -629	-5%	-$1.09K	﹤0.01%	3857
2025 Q2	$19.5K	Buy	12,157 +1,431	+13%	+$2.28K	﹤0.01%	3585
2025 Q1	$13.1K	Buy	10,726 +726	+7%	+$1.27K	﹤0.01%	3728
2024 Q4	$18.9K	Hold	10,000	–	–	﹤0.01%	3555
2024 Q3	$53.4K	Buy	+10,000	New	+$73.2K	﹤0.01%	3045
2024 Q1	–	Sell	-20	Closed	-$160	–	4781
2023 Q4	$160	Buy	+20	New	+$169	﹤0.01%	4500
2023 Q1	–	Sell	-10	Closed	-$216	–	4783
2022 Q4	$216	Buy	+10	New	+$218	﹤0.01%	4629

Other funds holding OTLK

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

GWM

Gilpin Wealth Management Denver, Colorado $145M AUM

PNC Financial Services Group's OTLK Position: Q2 2026 in Review

PNC Financial Services Group held its Outlook Therapeutics (OTLK) position steady in Q2 2026 at 25,000 shares worth $39.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3464.

PNC Financial Services Group first reported a position in OTLK in Q4 2022 and has held it in 10 quarters since. The position peaked at $53.4K in Q3 2024. 69 funds tracked by Wall St. Rank hold OTLK as of Q2 2026.

PNC Financial Services Group held 25,000 shares of Outlook Therapeutics worth $39.8K as of Q2 2026.
PNC Financial Services Group left its Outlook Therapeutics share count unchanged in Q2 2026.
Outlook Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3464 holding.
PNC Financial Services Group first reported a position in Outlook Therapeutics in Q4 2022 and has held it in 10 quarters since.
PNC Financial Services Group's Outlook Therapeutics position peaked at $53.4K in Q3 2024.
69 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.